NCT02287272View on ClinicalTrials.gov

Drug-drug Interaction Study of CHF5993 With Cimetidine

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

September 30, 2014

Conditions
COPD
Interventions
DRUG

CHF 5993 pMDI

4 inhalations of CHF 5993 pMDI (BDP/FF/GB 100/6/25 micrograms per actuation) giving a total dose of 400, 24, 100 micrograms of BDP, FF, GB

DRUG

Cimetidine plus CHF5993 pMDI

Cimetidine 800 milligrams twice daily for 6 days. On the fourth day, in addition, 4 inhalations of CHF5993 pMDI (BDP/FF/GB total dose 400/24/100 micrograms)

Trial Locations (1)

2060

Life Science Services SGS Belgium NV, Antwerp

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT02287272 - Drug-drug Interaction Study of CHF5993 With Cimetidine | Biotech Hunter | Biotech Hunter